What's New in Neurofeedback

A Monthly Summary of News and Events

Vol. 5 No. 7 - July 2002

This newsletter is sponsored by EEG Spectrum International Intl, Inc.,
a leader in providing clinical service and training professionals.

Past issues are available at www.eegspectrum.com/newsletter/
Information on how to subscribe or cancel a subscription appear at the end.
The opinions related in this newsletter reflect those of the author only.
Copyright (C) 2002 by EEG Spectrum International Intl, Inc. All rights reserved.



  • Announcements  - News
  • In the Spotlight     - Research Methodology in Neurofeedback
  • News & Reviews - Books & journal papers
  • Events & Locations - Conferences, Courses
  • Last Word               - Neurotherapy Offices in the U.S.

  •  

    Announcements


     

    In the Spotlight

    Research Methodology in Neurofeedback

    by Siegfried Othmer (July 15, 2002)

    A couple of recent scientific papers on the placebo effect reached the popular media, and prompt us to revisit the whole issue of how research might be done to everyone's satisfaction in neurofeedback. The first of these articles was a review of some 47 studies of anti-depressants that had been submitted to the FDA to gain approval for anti-depressant medications. In more than half of those studies, the drugs did no better than placebo. And overall, the improvement with drugs was only 18% greater than it was with placebos. The second of these studies involved functional imagery of drug responders, placebo responders, and non-responders. It found that placebo responders also showed changes in their functional imagery, and that these changes differed from those induced by the effective medications.

    These studies elevate the importance of the placebo effect once again in everyone's considerations, which can only serve to increase the burden of proof for neurofeedback. Our traditional answer to this challenge has been to point out that the placebo effect is not really on the other team as far as neurofeedback is concerned. Let me explain. From the perspective of drug interventions, the placebo is the catch-all phrase that subsumes all mechanisms other than the drug itself by which recovery may have been achieved. This includes spontaneous recovery, self-regulation-induced recovery, "the natural course of the disease" (e.g., natural waxing and waning of symptoms), and the results of changes in the psychodynamic milieu.

    In another recent study reviewing the placebo effect, it was shown that the majority of the benefit being ascribed to the placebo could be understood in terms of the "natural course of the disease." This is particularly true of depression, where episodes of depression are usually episodic, and recovery is achieved in time regardless of any intervention. However, this still leaves room for a "real" placebo effect of some significance. And this real placebo effect is presumably mediated by "spontaneous" or psychodynamically mediated changes in the quality of brain self-regulation. The possibility of such a self-regulation response helps to make the case for neurofeedback. It does not undermine it. Presumably the natural waxing and waning of depression and other conditions is also reflective of changes in the quality of brain self-regulation. From our perspective, then, the placebo effect, in all its manifestations, is just a stalking horse for self-regulation-mediated recovery. As such, it is our ally, and we are inclined to take umbrage at the dismissal of a real change as being "just a placebo effect."

    We have to take skeptics where they are, however, and the question will still be asked, what part of neurofeedback-induced recovery is ascribable to "specific" and to "non-specific" effects of the training. The best study to answer this question was Barry Sterman's serendipitously fully controlled, fully blinded cat study with the monomethylhydrazine. However, if we have to answer this same question with regard to each of the conditions we work with, what are we to do?

    The traditional answer has been to compare the active treatment with sham treatment, or to do reversal designs. Reversal designs are no longer ethically permitted (we are not allowed to make people worse), and even placebo designs have their ethical problems. But let's pursue the idea of sham-training a little further. It is extraordinarily difficult to do well. When Sterman did it, he acknowledged that trainees in fact discovered the subterfuge (no surprise). So the blind was broken, and the whole objective of doing a blinded study was not met. To do sham-training well, we have to simulate everything about the person's EEG, including in particular the movement artifacts and the eye-blink artifacts. The only way to do this successfully is to work somehow with the person's actual EEG.

    The more difficult standard to meet is that the clinician must be just as invested in success with the placebo treatment as with the experimental treatment, so that any placebo effect may be invoked. How do we fool the clinician who is at the controls into being motivated? The obvious answer is that we must employ an active treatment that also promises some benefit, rather than a total sham treatment. Even having done this, an asymmetry prevails. The clinician knows which is the experimental design, and which is the "B" design. There will be a natural tendency to "lean" in favor of the experimental treatment. The only way for a true "equipoise" to exist with respect to two treatments is for the clinician not to know which is better, and therefore to be motivated to succeed with both.

    We have here devised what I think is the perfect experimental design for neurofeedback, an A/B design between two active treatments in which a fundamental doubt exists as to which is better, and outcomes are compared. In this approach, we may lose 'contrast' between treatment and sham, but we heighten our sensitivity to differential effects. We already know that it is not a big deal to demonstrate recovery from depression. What the world will take notice of is differential effects of specific treatment protocols.

    Now I will point out that in our clinical work, with our generic protocols, we have in fact been working with this research design all along. Essentially all of our training protocols come in pairs, and are used as necessary to balance each other. The original training on the midline at Cz bifurcated for us into left- and right-hemisphere specificity of "C3beta" and "C4SMR" training. The more recent "C3-C4" training is bifurcating for us into a combination of F3-F4 and P3-P4. Higher-frequency training is complemented by lower-frequency training, etc. Each new client faces the clinician with fundamental ambiguities about protocols that are only resolved on the basis of the differential effects of each protocol.

    An analogy that comes to mind is the optometrist who refines his choice of optical correction by means of A/B comparisons. This approach allows much greater refinement than the single-ended approach of "can you read this?" Eventually the optometrist reaches the point where the person can no longer tell which is better. Clinicians using our approach likewise do not settle down to a single protocol until an equivalent resolution is obtained by an elaborate A/B comparison process. Because of the high responsiveness of the individual to specific protocols in-session, feedback is usually quick. This means that the therapist is also in a relatively fast feedback loop of typically no more than a few minutes, but lasting at most a session or two.

    This gives neurofeedback practitioners an enormous advantage over pharmacologists. After all, the 250 studies on Ritalin don't help to decide whether a particular child will be helped, and at what dosage. They are not much good in deciding what to do in the moment. By contrast, the neurofeedback practitioner is using best research practice with each and every client. So our answer to those who ask: "where are your controlled studies?" is that we are doing them, one subject at a time. There is almost never a time when we are not doing what would be called for in a "best-practices" controlled research design. Things can't get much better than this.

     


    News & Reviews NEW BOOKS

    Epilepsy and Sleep: Physiological and Clinical Relationships
    by Dudley S. Dinner, Hans O. Luders

    Reviews sleeping disorder symptoms which may in fact be caused by (undiagnosed) epilepsy. -www.amazon.com/exec/obidos/ASIN/0122167708/top100

    Magnetic Stimulation of the Human Nervous System
    by K. R. Mills
    Comprehensive review of methods and clinical applications of magnetic brain stimulation. -www.amazon.com/exec/obidos/ASIN/0192629867/top100

    Research Basis for Autism Intervention
    by Eric Schopler, Nurit Yirmiya, Cory Shulman
    Reviews of several areas of intervention, including preschool education, residential treatment for adults, treatment with drugs, and treatment for sleep problems -www.amazon.com/exec/obidos/ASIN/030646585X/top100

    Anxiety, Depression, and Emotion
    by Richard Davidson
    Basic research in emotion and emotional dysfunction in depression and anxiety. -www.amazon.com/exec/obidos/ASIN/0195133587/top100

    Trauma and Addiction: Ending the Cycyle of Pain Through Emotional Literacy
    by Tian Dayton
    Interconnection of trauma and addictive behavior -- why they can become an unending cycle of self-medicating and more pain. -www.amazon.com/exec/obidos/ASIN/1558747516/top100

    Handbook of Developmental Cognitive Neuroscience
    by Charles A. Nelson, Monica Luciana
    Recent technological advances have yielded methods that can be safely used to study structure-function relations and their development in children's brains. -www.amazon.com/exec/obidos/ASIN/026214073X/top100

     


    JOURNAL PAPERS

    Guidelines for the use of EEG methodology in the diagnosis of epilepsy : European guidelines on EEG methodology that focuses on the diagnosis of epilepsy. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12067321

    Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. : Most studies indicate that slow-frequency repetitive TMS (rTMS) and higher frequency rTMS have antidepressant properties; however, effect sizes are heterogeneous and the durability of antidepressant effects is largely unknown. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12057034

    Regional patterns of brain activity in adults with a history of childhood-onset depression : Women with childhood depression had higher right midfrontal alpha suppression, and men with childhood depression had higher left midfrontal alpha suppression. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12042180

    Perception of emotional chimeric faces in schizophrenia: right hemisphere dysfunction. : A specific deficit in right hemisphere attentional functions is found in schizophrenia. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12050469

    Neuropsychological deficits and opiate abuse. : Risk of neuropsychological impairment is greater in opiate abusers, and that recovery may occur during abstinence. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12062785

    New developments in stroke rehabilitation. : Functional magnetic resonance imaging and transcranial magnetic stimulation are among the new techniques broadening our understanding of neuroanatomic relationships involved in brain injury recovery. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12052278

    Response inhibition deficits in obsessive-compulsive disorder. : OCD subjects exhibit deficits in behavioral and cognitive inhibition, which may underlie the repetitive symptomatic behaviors of the disorder. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12057828

    Extreme male brain theory of autism. : Two neglected dimensions for understanding human sex differences are 'empathising' (female) and 'systemizing' (male). Autism may be considered as an extreme of the normal male profile. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12039606

    Neuropsychology of epilepsy. : Authors recommend systematic cognitive tasking, termed "neuropsychological EEG activation", during standard EEG recordings to identify seizure-precipitating factors. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=11902322

    Cognitive impairment in remission in bipolar affective disorder. : Patients with mania and unipolar depression show greater residual impairment in more posterior cortical function (temporal lobe) than frontal lobe function in remission. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12027040

    Anterior cingulate: single neuronal signals related to degree of reward expectancy. : Specific neurons in the anterior cingulate cortex are responsive to reward expectancy, a possible animal model for obsessive-compulsive disorder and drug abuse. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12040201

    Brain anatomy and sensorimotor gating in Asperger's syndrome. : Asperger's syndrome is associated with abnormalities in fronto-striatal pathways resulting in defective sensorimotor gating, and this may explain their difficulties inhibiting repetitive thoughts, speech and actions. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12077008

    Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder? : Affective illnesses may reflect an underdeveloped (or atrophied) prefrontal region, leading to loss of cortical modulation of limbic emotional networks. www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?form=6&db=m&uid=12071513

     


     

    Events & Locations

    Upcoming Courses

      4-Day Comprehensive
    • Seattle, WA -Aug 15-18
    • Washington DC -Sep 26-29

    Prerequisites: All Adv. classes require successful completion of the 4 Day Comprehensive Beta/SMR.
    * Advanced Practicum requires 150 hours direct NF clinical experience.
    More info at www.eegspectrum.com/course

    Conferences for Neurofeedback Clinicians & Researchers

    CONFERENCELOCATIONDATES
    SNR - http://www.snr-jnt.orgScottsdale, AZ Sep 12-15


     

    Last Word

    Distribution of Neurotherapy Offices in America

    A crude survey of neurotherapy offices in the U.S. finds the most in California (182), the least in Vermont and North Dakota (0), and the highest per capita in, of all places, Idaho!?


    The figure above shows the neurotherapy saturation (offices per million residents in a state). The data in table format is below.

                       offices  per Million residents
        Alabama               1        0
        Alaska                5        8
        Arizona              23        5
        Arkansas              6        2
        California          182        6
        Colorado             31        8
        Connecticut          13        4
        Delaware              2        3
        D.C.                  3        6
        Florida              39        3
        Georgia              21        3
        Hawaii                7        6
        Idaho                12       10
        Illinois             32        3
        Indiana               1        0
        Iowa                  4        1
        Kansas               11        4
        Kentucky              5        1
        Louisiana             6        1
        Maine                 4        3
        Maryland             17        3
        Massachusetts        25        4
        Michigan             19        2
        Minnesota            20        4
        Mississippi           3        1
        Missouri              8        1
        Montana               4        5
        Nebraska              7        4
        Nevada                6        3
        New Hampshire         3        3
        New Jersey           28        3
        New Mexico            6        3
        New York             72        4
        North Carolina       17        2
        North Dakota          0        0
        Ohio                 25        2
        Oklahoma             12        4
        Oregon               14        4
        Pennsylvania         27        2
        Rhode Island          3        3
        South Carolina        7        2
        South Dakota          1        1
        Tennessee            11        2
        Texas               112        6
        Utah                  9        4
        Vermont               0        0
        Virginia             20        3
        Washington           38        7
        West Virginia         3        2
        Wisconsin            11        2
        Wyoming               5       10
        Puerto Rico           5        2
    

    Here are all the cities and towns where neurotherapy offices were located for this survey. (If I missed your office, I apologize. This survey was a merge and duplicate purge of EEG Spectrum affiliate offices and Neurofeedback Yellow Pages listings, http://www.skiltopo.com/nfyp/ )

    ALABAMA -- Birmingham

    ALASKA -- Anchorage, Fairbanks, Soldotna

    ARIZONA -- Cave Creek, Clarkdale, Glendale, Lakeside, Litchfield Park, Mesa, Parker, Peoria, Phoenix, Prescott, Scottsdale, Sedona, Show Low, Tempe, Tucson

    ARKANSAS -- Fayetteville, Harrison, Jonesboro, Little Rock, White Hall

    CALIFORNIA -- Anaheim, Auburn, Bakersfield, Berkeley, Beverly Hills, Bonita, Brea, Calabasas, Calimesa, Camarillo, Canoga Park, Carmel Valley, Cerritos, Chico, Claremont, Columbia, Corte Madera, Cotati, Culver City, Cupertino, Dana Point, Del Mar, Diamond Bar, El Cerrito, El Dorado Hills, Encinitas, Encino, Escondido, Falls Church, Fountain Valley, Fremont, Fresno, Fullerton, Glendale, Grizzly Flats, Half Moon Bay, Hesperia, Hollywood, Huntington Beach, Irvine, La Canada, La Habra, La Jolla, Laguna Hills, Livermore, Long Beach, Los Angeles, Los Banos, Los Gatos, Los Osos, Malibu, Marin County, Marina Del Rey, Menlo Park, Merced, Milford, Mill Valley, Napa, Newport Beach, North Hollywood, Northridge, Ojai, Orange, Pacific Grove, Palm Springs, Palmdale, Palo Alto, Pasadena, Placerville, Pleasanton, Ramona, Rancho Bernardo, Rancho Cucamonga, Rancho Mirage, Redlands, Redondo Beach, Reseda, Riverside, Sacramento, San Diego, San Francisco, San Jose, San Juan Capistrano, San Leandro, San Luis Obispo, San Mateo, San Rafael, Santa Barbara, Santa Clarita, Santa Cruz, Santa Maria, Santa Monica, Santa Paula, Santa Rosa, Sausalito, Seal Beach, Sherman Oaks, Simi Valley, Stockton, Studio City, Tahoe City, Tehachapi, Temecula, Thousand Oaks, Topanga, Torrance, Tustin, Twenty Nine Palms, Ventura, Walnut Creek, West Hollywood, West Los Angeles, Westlake Village, Willow Creek, Yuba City

    COLORADO -- Aspen, Boulder, Colorado Springs, Denver, Englewood, Fort Collins, Greeley, Lakewood, Littleton, Pueblo, Westminster, Woodland Park

    CONNECTICUT -- Derby, Middletown, Milford, New Haven, Newington, Redding, Ridgefield, Stratford, Waterford, West Hartford, Westport

    DELAWARE -- Boca Raton, Wilmington

    DISTRICT OF COLUMBIA -- Washington

    FLORIDA -- Bonita Springs, Boynton Beach, Cocoa, Cocon, Cooper City, Coral Gables, Davie, Daytona Beach, Deerfield Beach, Fort Lauderdale, Fort Myers, Gainesville, Jacksonville, Lake Worth, Maitland, Melbourne, Miami, Orlando, Palm Beach Gardens, Pembroke Pines, Pensacola, Point St. Lucie, Redington Shores, Sarasota, South Miami, Tallahassee, Tampa, Venice, West Palm Beach, Winter Park

    GEORGIA -- Athens, Atlanta, Augusta, Conyers, Decatur, Douglasville, Dunwoody, Gainesville, Griffin, Jonesboro, Macon, McDowough, Saint Simons Island, Thomasville, Tucker, Woodstock

    HAWAII -- Honolulu, Kailua, Kamuela, Waikoloa

    IDAHO -- Arlington Hgts, Boise, Coeur d'Alene, Eagle, Hailey, Kellogg, Nampa, Rigby

    ILLINOIS -- Anderson, Bloomington, Champaign-Urbana, Chicago, Evanston, Evansville, Gary, Greenfield, Highland Park, Hobart, Hoffman Estates, Kokomo, Matteson, Mount Prospect, Naperville, New Lenox, Northbrook, Olympia Fields, Rockford, Schaumburg, Willowbrook, Winnetka

    INDIANA -- Munster

    IOWA -- Atlantic, Des Moines, Mount Pleasant, West Des Moines

    KANSAS -- Emporia, Fairway, Greenwood, North Newton, Pittsburg, Topeka

    KENTUCKY -- Goshen, Lexington, Louisville, Shelbyville

    LOUISIANA -- Baton Rouge, Lafayette, Lake Charles, Metairie, Shreveport, Slidell

    MAINE -- Bangor, Biddeford, Bucksport, Yarmouth

    MARYLAND -- Aberdeen, Baltimore, Bethesda, Catonsville, Chester, Chevy Chase, Dayton, Ellicott City, Hampstead, Laurel, Lutherville, Olney, Salisbury, Wheaton

    MASSACHUSETTS -- Amherst, Andover, Beverly, Boston, Cambridge, Great Barrington, Greenfield, Hadley, Holliston, Lexington, Newton Centre, Northampton, Petersham, Waltham, Wellesley, West Barnstable, Worcester

    MICHIGAN -- Ann Arbor, Bay City, Bloomfield Hills, Chanhassen, Crystal, Detroit, Dexter, East Lansing, Grand Haven, Grand Rapids, Holland, Kalamazoo, Lansing, Northville, Port Sanilac, Saginaw, St. Joseph

    MINNESOTA -- Duluth, Edina, Excelsior, Grand Marais, Minneapolis, North Mankato, Perham, Richfield, Rochester, Rogers , Sauk Rapids, St. Louis Park, St. Paul, Stillwater

    MISSISSIPPI -- Columbus, Flowood, Vicksburg

    MISSOURI -- Amory, Bel-Nor, Belton, Columbia, Kansas City, St. Louis

    MONTANA -- Great Falls, Helena, Missoula, Whitefish

    NEBRASKA -- Broken Bow, Crete, Grand Island, Hastings, Lincoln, Milford

    NEVADA -- Carson City, Henderson, Las Vegas, Reno

    NEW HAMPSHIRE -- Contoecook, East Kingston, Londonderry

    NEW JERSEY -- Atlantic Highlands, Audubon, Brick, Chester, Denville, Elberon, Englewood Cliffs, Fair Lawn, Glouster City, Jersey City, Marlton, Matawan, Moorestown, Mountain Lakes, Northvale, Princeton, Princton, Ringwood, Sea Girt, Somerville, South Plainsfield, Tenafly, Turnersville, West Orange, Williamstown

    NEW MEXICO -- Albuquerque, Farmington, Santa Fe

    NEW YORK -- Akron, Baldwinsville, Bayside, Beachwood, Belle Harbor, Binghamton, Bronx, Brooklyn, Chappaqua, Commack, Croton-On-Hudson, East Meadow, East Northport, East Setauket, Endicott, Flushing, Great Neck, Hampton Bays, Harrison, Hartsdale, Huntington, Ithaca, Kingston, Long Island City, Manhasset, Middle Island, New Paltz, New Platz, New York, New York City, North Bellmore, Nyack, Ossining, Plainview, Port Jefferson Station, Putnam Valley, Saratoga Springs, Shortsville, Staten Island, Stony Brook, Suffern, Valley Cottage, Valley Stream, Warwick, Yonkers

    NORTH CAROLINA -- Asheville, Chapel Hill, Charlotte, Fayetteville, Greensboro, Greenville, Hillsborough, Kernersville, Raleigh, Winston-Salem, Youngsville

    OHIO -- Akron, Canton, Centerville, Chagrin Falls, Cincinnati, Cleveland, Columbus, Elyria, Gahanna, London, Pickerington, Piqua, Shaker Heights, Sylvania, Toledo, Wadsworth, Westlake, Whitehouse

    OKLAHOMA -- Ada, Altus, Enid, Lawton, Norman, Oklahoma City, Tulsa

    OREGON -- Amity, Ashland, Corvallis, Eugene, Klamath Falls, Lake Oswego, Lebanon, Medford, Portland, Sweethome, Tigard

    PENNSYLVANIA -- Allentown, Bala Cynwyd, Bethlehem, Bloomsburg, Carlisle, Chambersburg, Downingtown, Exton, Langhorne, Morrisville, Newtown, Philadelphia, Phoenixville, Plymouth Meeting, State College, Swarthmore, Trevose, Trooper, Washington, West Chester, Wyomissing, Yardley

    PUERTO RICO -- Caguas, Ponce, Rio Piedras, San Juan

    RHODE ISLAND -- Narragansett, Providence, Rumford

    SOUTH CAROLINA -- Beaufort, Columbia, Florence, Mount Pleasant, Myrtle Beach, Tryon

    SOUTH DAKOTA -- Rapid City

    TENNESSEE -- Bethel Springs, Chattanooga, Cordova, Franklin, Germantown, Knoxville, Memphis, Nashville

    TEXAS -- Abilene, Addison, Amarillo, Athens, Austin, Azle, Bay City, Bedford, Buffalo Gap, Carrollton, Cedar Park, College Station, Colleyville, Corpus Christi, Dallas, Denton, Desoto, El Paso, Euless, Fort Worth, Galveston, Grapevine, Hewitt, Houston, Hurst, Irving, Lake Dallas, Lewisville, Los Fresnos, Lubbock, Mesquite, Midland, Plano, Richmond, Roanoke, Rockport, Round Rock, San Antonio, Texarkana, Tyler, Vernon

    UTAH -- Bountiful, Logan, Murray, Orem, Provo, Salt Lake City, South Ogden, St. George

    VIRGINIA -- Abingdon, Alexandria, Ashland, Chantilly, Charlottesville, Chesapeake, Glen Allen, McLean, Midlothian, Newport News, Norfolk, Richmond, Roanoke, Trout Dale, Warrenton

    WASHINGTON -- Bainbridge Island, Bellevue, Bellingham, Bothell, Burlington, Colville, Edmonds, Everett, Gig Harbor, Kirkland, Lake Stevens, Lynwood, Mercer Island, Mount Vernon, Palouse, Pullman, Seattle, Snohomish, Spokane, Tacoma, Tukwila, Wenatchee

    WEST VIRGINIA -- Bluefield, Clarksburg, Parkersburg

    WISCONSIN -- Chippewa Falls, Eau Claire, Green Bay, Kenosha, Madison, Milwaukee, Oconomowoc, Wauwatosa

    WYOMING -- Casper , Jackson, Lyman, Newcastle, Wilson